Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: 20-Week Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia [Phase 2]
Phase 2 trial update for AKB-6548 in adults with chronic kidney disease and anemia; study completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: 42-Day Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia [Phase 2]
Phase 2 trial update for AKB-6548 in chronic kidney disease with anemia; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: Safety and Efficacy Study for AKB-6548 in Participants With Chronic Kidney Disease and Anemia [Phase 2]
Phase 2 clinical trial assessing safety and efficacy of AKB-6548 in adults with chronic kidney disease and anemia has completed, with result…
-
CLINICAL_TRIALS trial_result · 2022-06-27Clinical Trial Update: Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease [Phase 3]
Phase 3 trial evaluating vadadustat for correction of anemia in non-dialysis-dependent chronic kidney disease has completed, with results po…
-
FDA approval · 2022-06-16FDA Approved: FERAHEME — Supplemental Application (AMAG Pharmaceuticals, Inc.)
FDA approved a supplemental application for Feraheme (ferumoxytol) from AMAG Pharmaceuticals.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-06-13Clinical Trial Update: Pilot Study of Loop Diuretics Among Individuals Receiving Hemodialysis [Phase 2]
A Phase 2 pilot study evaluating loop diuretics in individuals undergoing hemodialysis has completed with results posted.
-
FDA approval · 2022-05-25FDA Approved: SEVELAMER CARBONATE FOR ORAL SUSPENSION — Supplemental Application (Dr. Reddys Laboratories Inc)
FDA approved a supplemental application for Sevelamer carbonate for oral suspension from Dr. Reddy's Laboratories, enabling a generic formul…
-
CLINICAL_TRIALS trial_result · 2022-05-25Clinical Trial Update: A Randomized, Double-blind, Active Control, Parallel Group, Titration, Multicenter Study to Evaluate the Efficacy and Safety of Fimasartan [Phase 3]
Phase 3 randomized trial assessing efficacy and safety of fimasartan in chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: Effects of Green Propolis Extract (EPP-AF) on Inflammation in Hemodialysis Patients. [Phase 1, Phase 2]
Phase 1/2 trial evaluating Green Propolis Extract (EPP-AF) effects on inflammation in patients with chronic kidney disease requiring chronic…
-
CLINICAL_TRIALS trial_result · 2022-05-17Clinical Trial Update: Study to Assess the Safety and Pharmacokinetics of AKB-6548 in Participants With Chronic Kidney Disease (CKD), Stages 3 and 4 [Phase 2]
Phase 2 trial assessing safety and pharmacokinetics of AKB-6548 in adults with CKD (stages 3-4) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-05-11Clinical Trial Update: Ixazomib for Desensitization [Phase 2]
Phase 2 clinical trial evaluating ixazomib for desensitization in kidney disease patients was completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-06Clinical Trial Update: Evaluate the Efficacy and Safety of Multiple Roxadustat Dosing Regimens for the Treatment of Anemia in Dialysis Participants With Chronic Kidney Disease [Phase 4]
Phase 4 trial evaluating multiple dosing regimens of roxadustat for anemia in dialysis-dependent chronic kidney disease; study completed.
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Trial of Pirfenidone to Prevent Progression in Chronic Kidney Disease [Phase 2]
Phase 2 trial investigating pirfenidone to prevent progression of chronic kidney disease. The study status is unknown.
-
FDA approval · 2022-04-25FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Westminster Pharmaceuticals, LLC)
The FDA approved Westminster Pharmaceuticals' supplemental application for sevelamer carbonate, enabling its generic product to be marketed.…
-
CLINICAL_TRIALS trial_result · 2022-04-13Clinical Trial Update: Renal Tubular Injury and Transplant Outcomes in Cardiac Recipients Converting From IR Tacrolimus to XR Tacrolimus [Phase 4]
Phase 4 clinical trial evaluating renal tubular injury and transplant outcomes when converting from IR tacrolimus to XR tacrolimus in cardia…
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: Anakinra vs. Steroids for the Treatment of Gout Attacks in Patients With Renal Disease (ASGARD): A Feasibility Study [Phase 2, Phase 3]
A feasibility study comparing anakinra versus steroids for treating gout attacks in patients with renal disease (ASGARD) completed.
-
FDA approval · 2022-04-05FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Sevelamer carbonate by Aurobindo Pharma Limited. This approval enables the generic product to be…
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Multiple Doses of DM199 in Patients With Chronic Kidney Disease (REDUX) [Phase 2]
Phase 2 trial update for DM199 in chronic kidney disease has completed enrollment and status.
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Chlorthalidone in Chronic Kidney Disease [Phase 2]
Phase 2 trial update for chlorthalidone in chronic kidney disease has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: Berberine Prevent Contrast-induced Nephropathy in Patients With Diabetes [Phase 4]
Phase 4 clinical trial evaluating berberine to prevent contrast-induced nephropathy in patients with diabetes.
-
CLINICAL_TRIALS trial_result · 2022-03-23Clinical Trial Update: Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease [Phase 2]
Phase 2 trial update assessing safety and efficacy of ANG-3070 in chronic kidney disease with glomerular disease and proteinuria.
-
CLINICAL_TRIALS trial_result · 2022-03-10Clinical Trial Update: Safety and Effectiveness Evaluation of Two Kinds of Peritoneal Dialysate [Phase 4]
A Phase 4 trial evaluating safety and effectiveness of two types of peritoneal dialysate for chronic kidney failure.
-
CLINICAL_TRIALS trial_result · 2022-03-07Clinical Trial Update: Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis. [Phase 2]
Phase 2 trial assessing the optimal starting subcutaneous dose of Mircera for maintenance treatment of anemia in pediatric chronic kidney di…
-
CLINICAL_TRIALS trial_result · 2022-03-04Clinical Trial Update: Feasibility Study for Heparin-free Hemodialysis With the Dialyzer With Endexo™ [NA]
Feasibility study completed on a heparin-free hemodialysis approach using the Dialyzer With Endexo, with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: The Iron and Muscle Study [Phase 4]
Phase 4 trial update on the Iron and Muscle Study evaluating CKD patients with iron deficiency.